Cardinal Health, Inc.
CAH is off the screens on one check: a base has formed.
Measured against the base-and-breakout thresholds. The other screens use their own numbers, so a name can miss here and still be a fair-looking chart.
Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.
Cardinal Health, Inc. is not on any of the screens right now. Its relative strength rating is 88, and it sits in Drug Wholesalers.
Its industry has too few members to make an index of, so it is read against the S&P 500 and can only be turning, caution or unconfirmed.
- Ex-dividendconfirmedin 49dEx-dividend dateJan 4, 2027
On average 6.2% either way across its last 8 reports.
Checking your subscription…
Close before the report day to close after it, so it holds whether the company reported before the open or after the close.
No figures in US GAAP filings for this company. Most foreign listings report under international standards, which this does not read.
Held by 2 of 46 tracked funds at the end of Q3 2026.
Last quarter: 1 bought new, 1 added.
Checking your subscription…
From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.
From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.
Headlines link to the publisher. We do not host, summarise or rank them, and a headline appearing here is not a view about the company.
Sold: Scherer Mary C., Hollar Jason M., Mason Stephen M, WEITZMAN DEBORAH, Alt Aaron E, Mayer Jessica L, Greene Michelle D..
Not counted above: 24 filings for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.
From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.
These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.
Checking your subscription…
No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.
No completed base to compare this one with yet.